System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Bruno Guerci is an expert in Endocrinology at Centre Hospitalier Universitaire de Nancy (France). As of October 2026, ScienceLeadR ranks Bruno Guerci in the top 1% of experts worldwide for Diabetes Mellitus and Glucose Metabolism Disorders. Bruno Guerci has authored 413 publications, the most recent in 2026, and is an investigator in 45 clinical trials, 5 of them ongoing. SLR score: 1,492 (community average: 125). How the SLR is computed.

LeadR Profile

Bruno Guerci Centre Hospitalier Universitaire de Nancy France
1 492 ScienceLeadR Reputation 1492

Unlock

Register Login
Network Map

Endocrinology

Subspecialties: Internal Medicine - Nephrology - Gastroenterology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1996 - 2026
Source: PubMed

Centre Hospitalier Universitaire de Nancy

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 413

Citations

Citations: 18 050 1st author: 68 Last author: 51 Unique author: 13

Main journals

Diabetes Metab 106
Ann Endocrinol (Paris) 29
Diabetes Care 26
Diabetes Obes Metab 22
Médecine des Maladies Métaboliques 18

Best Journals

N Engl J Med 6
Lancet 1
Lancet Diabetes Endocrinol 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Hospitalization outcomes in adults with type 2 diabetes mellitus treated with once-weekly insulin efsitora versus once-daily basal insulins: A post hoc analysis of the QWINT-1 to -4 randomized trials.
PMID 42829184 — diabetes mellitus, insulin glargine, hospitalization, insulin, insulins, therapeutics, hypoglycemia, diabetes mellitus, type 2		Diabetes Res Clin Pract20260
A reference framework for continuous glucose monitoring training and education among healthcare professionals - a multidisciplinary expert consensus.
PMID 42546973 — diabetes mellitus, education, continuous glucose monitoring		Diabetes Res Clin Pract20260
Continuous Glucose Monitoring in Older-Old With Type 2 Diabetes Mellitus: A Narrative Review of Evidence and Recommendations.
PMID 42472682 — diabetes mellitus, quality of life, aged, therapeutics, glycemic control, diabetes mellitus, type 2, continuous glucose monitoring		Diabetes Obes Metab20260
Mismatch Between Sensor and Symptoms: The Complex Reality of Hypoglycemia Around Exercise in Type 1 Diabetes Patients Using AID Systems.
PMID 42265052 — diabetes mellitus, exercise, insemination, artificial, heterologous, signs and symptoms, hypoglycemia, diabetes mellitus, type 1, continuous glucose monitoring		Diabetes Obes Metab20260
Economic burden of type 2 diabetes management in France according to clinical characteristics.
PMID 41804199 — diabetes mellitus, financial stress, insulin, retrospective studies, therapeutics, diabetes mellitus, type 2		Diabetes Obes Metab20260

Clinical Studies 45

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 6

By phase:

N/A 21
Phase 3 18
Phase 4 3
Phase 2 2
Phase 2/Phase 3 1

By status:

Completed 32
Unknown 6
Recruiting 4
Active not recruiting 1
Not yet recruiting 1
Terminated 1

By type:

Interventional 36
Observational 9

By Monocentric/Multicentric:

monocentric 9
multicentric2to4 1
multicentric5to9 7
multicentricup10 28

Main Topics

Cohort/Consortium Investigators 7

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Phase III Study to Investigate the Risk of Incident Heart Failure and Cardiovascular Death with Baxdrostat in Combination with Dapagliflozin in Participants with Increased Risk of Developing Heart Failure
2024-514506-32-00 — heart failure, heart		Phase 3Not yet recruiting2025
A randomized double blind placebo controlled multicenter study to evaluate the effect of inclisiran on preventing major adverse cardiovascular events in high risk primary prevention patients (VICTORION 1 PREVENT)
2022-502779-40-00 — cardiovascular diseases, primary prevention		Phase 3Active not recruiting2023
Clinical Evaluation of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in Adult Subjects With Type 1 Diabetes (CIP347)
NCT06739811 — diabetes mellitus, insulin, diabetes mellitus, type 1		N/ARecruiting2025
Role of High Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes
NCT06570278 — diabetes mellitus, high-throughput nucleotide sequencing, whole genome sequencing, genome, diagnosis		N/ARecruiting2024
Study of the Impact of PROximity Support for Patients With Type 1 DIABetes Treated With an Insulin Pump or Closed Loop
NCT06050642 — diabetes mellitus, nurses, quality of life, insulin, pharmacists, physicians, cost of illness, therapeutics, diabetes mellitus, type 1		N/ARecruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS